CC-95775 by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
CC-95775 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor.
CC-95775 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor.
What's Your Reaction?
